Literature DB >> 34978685

Validation of microRNA Target Genes Using Luciferase Reporter assay and Western Blot Analysis.

Pooja Panwalkar1,2, Atul Khire3,4, Neelam Shirsat3,5.   

Abstract

MicroRNA s regulate gene expression by binding to the 3'untranslated region (UTR) of the mRNA of their target genes. Identification of microRNA target genes enables the determination of their functional role in the cells. A single microRNA can target multiple genes, all of which have a microRNA binding site in their 3' UTR. Putative target genes can be identified using target prediction software and gene expression analysis of microRNA expressing cells. The validation of the putative target genes is carried out using the luciferase reporter assay and western blot analysis. This chapter describes the protocol for using these techniques for validation of putative microRNA target genes.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Luciferase reporter assay; MicroRNA; Target genes; Western blotting

Mesh:

Substances:

Year:  2022        PMID: 34978685     DOI: 10.1007/978-1-0716-1952-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway.

Authors:  Amit Gokhale; Ratika Kunder; Atul Goel; Rajiv Sarin; Aliasgar Moiyadi; Asha Shenoy; Chandrasekhar Mamidipally; Santosh Noronha; Sadhana Kannan; Neelam Vishwanath Shirsat
Journal:  J Cancer Res Ther       Date:  2010 Oct-Dec       Impact factor: 1.805

Review 3.  miR miR on the wall, who's the most malignant medulloblastoma miR of them all?

Authors:  Xin Wang; Borja L Holgado; Vijay Ramaswamy; Stephen Mack; Kory Zayne; Marc Remke; Xiaochong Wu; Livia Garzia; Craig Daniels; Anna M Kenney; Michael D Taylor
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.